The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Nonalcoholic Fatty Liver Disease: A Review and Update
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · cited 1×
“More recently, the NASH Clinical Research Network (CRN) devised a new system of staging of NAFLD [117].”
BackgroundManagement of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675 · cited 2×
“Bile acid sequestering agents [158, 159, 161, 176] Ursodeoxycholic acid (UDCA) Cholesterollowering; reduces inflammatory cytokine production ; ; – Small studies, one large RCT showed no benefit.”
BackgroundSteatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
The utility of radiological imaging in nonalcoholic fatty liver disease
Saadeh, S., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,110
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106 · cited 1×
“would have been misdiagnosed as steatosis only instead of NASH had the second biopsy not been performed [120].”
BackgroundPLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Old, L. J. (1985) · Science · doi:10.1126/science.2413547 · Cited by 1,895
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Carucci, P., Musso, A., De Paolis, P., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,439
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
Després, J.-P., Golay, A., & Sjöström, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044537 · Cited by 1,392 · cited 1×
“trial, obese and overweight subjects provided with 20 mg rimonabant experienced a significant decrease in waist circumference, triglycerides, and LFTs, and improvements in HDL, adiponectin levels, and insulin resistance [140].”
BackgroundDixon, J. B., Bhathal, P. S., & O'Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,360
Deurenberg, P., Deurenberg‐Yap, M., & Guricci, S. (2002) · Obesity Reviews · doi:10.1046/j.1467-789x.2002.00065.x · Cited by 1,326
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317797 · Cited by 1,298
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17797 · Cited by 1,296
Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients
Pratt, D. S., & Kaplan, M. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004273421707 · Cited by 1,203
(2017) · Arzneimittelforschung · doi:10.1055/s-00000175 · Cited by 1,134
Magnetic resonance elastography: Non-invasive mapping of tissue elasticity
Manduca, A., Oliphant, T. E., Dresner, M. A., Mahowald, J. L., Kruse, S. A., Amromin, E., Felmlee, J. P., Greenleaf, J. F., & Ehman, R. L. (2001) · Medical Image Analysis · doi:10.1016/s1361-8415(00)00039-6 · Cited by 1,103
AGA technical review on nonalcoholic fatty liver disease
Sanyal, A. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36572 · Cited by 1,072
Ziccardi, P., Nappo, F., Giugliano, G., Esposito, K., Marfella, R., Cioffi, M., D’Andrea, F., Molinari, A. M., & Giugliano, D. (2002) · Circulation · doi:10.1161/hc0702.104279 · Cited by 994 · cited 1×
“, TNF-a and IL-6) have also been observed following weight loss in obese patients [128].”
BackgroundAssessment of Hepatic Fibrosis With Magnetic Resonance Elastography
Yin, M., Talwalkar, J. A., Glaser, K. J., Manduca, A., Grimm, R. C., Rossman, P. J., Fidler, J. L., & Ehman, R. L. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.06.012 · Cited by 948
Davidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA · doi:10.1001/jama.281.3.235 · Cited by 947 · cited 1×
“In trials examining obese patients, pancreatic lipase inhibition has been associated with weight reduction and improvements in insulin resistance and LDL profiles [133, 134].”
BackgroundBeyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 925
Harrison, S. A., Oliver, D., Arnold, H. L., Gogia, S., & Neuschwander-Tetri, B. A. (2008) · Gut · doi:10.1136/gut.2007.146019 · Cited by 869
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 863
Pagano, G., Pacini, G., Musso, G., Gambino, R., Mecca, F., Depetris, N., Cassader, M., David, E., Cavallo-Perin, P., & Rizzetto, M. (2002) · Hepatology · doi:10.1053/jhep.2002.30690 · Cited by 753
Neuschwander-Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Oliver, D., & Bacon, B. R. (2003) · Hepatology · doi:10.1002/hep.1840380427 · Cited by 751
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
Harrison, S. A., Torgerson, S., Hayashi, P. H., Ward, J. A., & Schenker, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.08.005 · Cited by 731
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial
Lindor, K. D., Kowdley, K. V., Heathcote, J. E., Harrison, E. M., Jorgensen, R., Angulo, P., Lymp, J. F., Burgart, L., & Colin, P. (2004) · Hepatology · doi:10.1002/hep.20092 · Cited by 727 · cited 2×
“[173] published the largest trial to date, in which 166 patients with NASH were randomized to UDCA or placebo for 2 years.”
BackgroundA pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
Promrat, K., Lutchman, G., Uwaifo, G. I., Freedman, R. J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., et al. (2004) · Hepatology · doi:10.1002/hep.20012 · Cited by 726 · cited 1×
“[152], in a series of 18 patients, showed that treatment for 48 weeks with pioglitazone resulted in significant improvements in LFTs, steatosis, inflammation, and fibrosis.”
BackgroundAithal, G. P., Thomas, J. A., Kaye, P. V., Lawson, A., Ryder, S. D., Spendlove, I., Austin, A. S., Freeman, J. G., Morgan, L., & Webber, J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.047 · Cited by 721 · cited 1×
“[154] published similar results in another randomized trial in which 61 nondiabetic patients with biopsy-proven NASH were randomized to 12 months of pioglitazone therapy or placebo and then underwent repeat liver biopsy.”
ResultCrespo, J., Cayón, A., Fernández-Gil, P., Hernández-Guerra, M., Mayorga, M., Domínguez-Díez, A., Fernández-Escalante, J. C., & Pons-Romero, F. (2001) · Hepatology · doi:10.1053/jhep.2001.29628 · Cited by 693
Metformin in non-alcoholic steatohepatitis.
Marchesini, G., Bianchi, G., Tomassetti, S., Zoli, M., & Melchionda, N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06042-1 · Cited by 682
Metformin reverses fatty liver disease in obese, leptin-deficient mice.
Lin, H. Z., Yang, S. Q., Chuckaree, C., Kuhajda, F., Ronnet, G., & Diehl, A. M. (2000) · Nature Medicine · doi:10.1038/79697 · Cited by 673
Ratziu, V., Giral, P., Jacqueminet, S., Charlotte, F., Hartemann–Heurtier, A., Serfaty, L., Podevin, P., Lacorte, J., Bernhardt, C., Bruckert, E., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.078 · Cited by 625 · cited 2×
“[157, 158] reported 3-year follow-up data on 40 of these patients who underwent repeat biopsies.”
BackgroundMethodTherapeutic effects of restricted diet and exercise in obese patients with fatty liver
Ueno, T., Sugawara, H., Sujaku, K., Hashimoto, O., Tsuji, R., Tamaki, S., Torimura, T., Inuzuka, S., Sata, M., & Tanikawa, K. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80287-5 · Cited by 609
Haukeland, J. W., Damås, J. K., Konopski, Z., Løberg, E. M., Haaland, T., Goverud, I., Torjesen, P. A., Birkeland, K., Bjøro, K., & Aukrust, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.02.011 · Cited by 603
Laurin, J., Lindor, K. D., Crippin, J. S., Gossard, A., Gores, G. J., Ludwig, J., Rakela, J., & McGill, D. B. (1996) · Hepatology · doi:10.1002/hep.510230624 · Cited by 566
Vuppalanchi, R., & Chalasani, N. (2009) · Hepatology · doi:10.1002/hep.22603 · Cited by 563
Ding, X., Saxena, N. K., Lin, S., Gupta, N., & Anania, F. A. (2006) · Hepatology · doi:10.1002/hep.21006 · Cited by 557
Park, S. H., Kim, P. N., Kim, K. W., Lee, S. W., Yoon, S. E., Park, S. W., Ha, H. K., Lee, M.-G., Hwang, S., Lee, S.-G., et al. (2006) · Radiology · doi:10.1148/radiol.2391050361 · Cited by 542
Long term prognosis of fatty liver: risk of chronic liver disease and death
Dam-Larsen, S., Franzmann, M., Andersen, I. B., Christoffersen, P., Jensen, L. B., Sørensen, T. I. A., Becker, U., & Bendtsen, F. (2004) · Gut · doi:10.1136/gut.2003.019984 · Cited by 508
Harnois, D. (2009) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(09)79298-0 · Cited by 505
Cytokines and Nash: A Pilot Study of the Effects of Lifestyle Modification and Vitamin E
Kugelmas, M., Hill, D. B., Vivian, B., Marsano, L., & McClain, C. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50316 · Cited by 504
Ratziu, V., Massard, J., Charlotte, F., Messous, D., Imbert-Bismut, F., Bonyhay, L., Tahiri, M., Munteanu, M., Thabut, D., Cadranel, J. F., et al. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-6 · Cited by 492
Appetite suppression and weight loss after the cannabinoid antagonist SR 141716
Colombo, G., Agabio, R., Diaz, G., Lobina, C., Reali, R., & Gessa, G. L. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00322-1 · Cited by 487
Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease
Jou, J., Choi, S., & Diehl, A. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091981 · Cited by 482
Kupffer cells in non-alcoholic fatty liver disease: The emerging view
Baffy, G. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.008 · Cited by 473
Natural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies
Fassio, E., �lvarez, E., Dom�nguez, N., Landeira, G., & Longo, C. (2004) · Hepatology · doi:10.1002/hep.20410 · Cited by 469
Yokohama, S., Yoneda, M., Haneda, M., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Tokusashi, Y., Miyokawa, N., & Nakamura, K. (2004) · Hepatology · doi:10.1002/hep.20420 · Cited by 458
Huang, M. A., Greenson, J. K., Chao, C., Anderson, L., Peterman, D., Jacobson, J., Emick, D., Lok, A. S., & Conjeevaram, H. S. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41334.x · Cited by 444
Bugianesi, E., Manzini, P., D'Antico, S., Vanni, E., Longo, F., Leone, N., Massarenti, P., Piga, A., Marchesini, G., & Rizzetto, M. (2004) · Hepatology · doi:10.1002/hep.20023 · Cited by 440
Abdelmalek, M. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02691-0 · Cited by 439
Sanyal, A. J., Mofrad, P. S., Contos, M. J., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Clore, J., & Mills, A. S. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00457-4 · Cited by 437
Hickman, I. J., Jonsson, J. R., Prins, J. B., Ash, S., Purdie, D. M., Clouston, A. D., & Powell, E. E. (2004) · Gut · doi:10.1136/gut.2003.027581 · Cited by 435
Verdich, C., Toubro, S., Buemann, B., Lysgård Madsen, J., Juul Holst, J., & Astrup, A. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801655 · Cited by 434
McKenney, J. M., Davidson, M. H., Jacobson, T. A., & Guyton, J. R. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.02.030 · Cited by 431
Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics
Callewaert, N., Vlierberghe, H. V., Hecke, A. V., Laroy, W., Delanghe, J., & Contreras, R. (2004) · Nature Medicine · doi:10.1038/nm1006 · Cited by 418
Hasegawa, T., Yoneda, M., Nakamura, K., Makino, I., & Terano, A. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01083.x · Cited by 408
Hepatic effects of dietary weight loss in morbidly obese subjects
Andersen, T., Gluud, C., Franzmann, M.-B., & Christoffersen, P. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90942-5 · Cited by 407
Metformin in the treatment of patients with non‐alcoholic steatohepatitis
Uygun, A., Kadayifci, A., Isik, A. T., Ozgurtas, T., Deveci, S., Tuzun, A., Yesilova, Z., Gulsen, M., & Dagalp, K. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01888.x · Cited by 405
Lactic Acidosis in Patients with Diabetes Treated with Metformin
Misbin, R. I., Green, L., Stadel, B. V., Gueriguian, J. L., Gubbi, A., & Fleming, G. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380415 · Cited by 403
YOSHIJI, H., KURIYAMA, S., YOSHII, J., IKENAKA, Y., NOGUCHI, R., NAKATANI, T., TSUJINOUE, H., & FUKUI, H. (2001) · Hepatology · doi:10.1053/jhep.20001.28231 · Cited by 397
A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis.
Caldwell, S. H., Hespenheide, E. E., Redick, J. A., Iezzoni, J. C., Battle, E. H., & Sheppard, B. L. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03553.x · Cited by 394
Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis
Longo, R., Pollesello, P., Ricci, C., Masutti, F., Kvam, B. J., Bercich, L., Croce, L. S., Grigolato, P., Paoletti, S., De Bernard, B., et al. (1995) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880050311 · Cited by 387
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case–Control Study
Brea, A., Mosquera, D., Martín, E., Arizti, A., Cordero, J. L., & Ros, E. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160613.57985.18 · Cited by 387
Effect of weight reduction on hepatic abnormalities in overweight patients
Palmer, M., & Schaffner, F. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91169-7 · Cited by 374
Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial
Nair, S., Diehl, A. M., Wiseman, M., Farr, G. H., & Perrillo, R. P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02025.x · Cited by 369 · cited 3×
“[166] followed 15 patients who received metformin for 1 year and demonstrated initial improvement in LFTs, but the effect was not sustained.”
BackgroundResultInfluentialThe diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis
Poynard, T., Ratziu, V., Naveau, S., Thabut, D., Charlotte, F., Messous, D., Capron, D., Abella, A., Massard, J., Ngo, Y., et al. (2005) · Comparative Hepatology · doi:10.1186/1476-5926-4-10 · Cited by 368
Weston, S. R., Leyden, W., Murphy, R., Bass, N. M., Bell, B. P., Manos, M. M., & Terrault, N. A. (2005) · Hepatology · doi:10.1002/hep.20554 · Cited by 364
Chitturi, S., Farrell, G., Frost, L., Kriketos, A., Lin, R., Liddle, C., Samarasinghe, D., & George, J. (2002) · Hepatology · doi:10.1053/jhep.2002.34738 · Cited by 362
Fatty Infiltration of Liver in Hyperlipidemic Patients
Assy, N., Kaita, K., Mymin, D., Levy, C., Rosser, B., & Minuk, G. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005661516165 · Cited by 360
Dufour, J., Oneta, C. M., Gonvers, J., Bihl, F., Cerny, A., Cereda, J., Zala, J., Helbling, B., Steuerwald, M., & Zimmermann, A. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.025 · Cited by 358
Diagnosis and Therapy of Nonalcoholic Steatohepatitis
Torres, D. M., & Harrison, S. A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.077 · Cited by 354
PALMENTIERI, B., DESIO, I., LAMURA, V, MASARONE, M., VECCHIONE, R., BRUNO, S., TORELLA, R., & PERSICO, M. (2006) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.03.021 · Cited by 341
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
Kral, J. G., Thung, S. N., Biron, S., Hould, F.-S., Lebel, S., Marceau, S., Simard, S., & Marceau, P. (2004) · Surgery · doi:10.1016/j.surg.2003.10.003 · Cited by 322
Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice
Feldstein, A. E., Canbay, A., Guicciardi, M. E., Higuchi, H., Bronk, S. F., & Gores, G. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00460-4 · Cited by 320
Chitturi, S., Farrell, G. C., Hashimoto, E., Saibara, T., Lau, G. K., Sollano, J. D., & NAFLD, T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05001.x · Cited by 312
A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis
Basaranoglu, M., Acbay, O., & Sonsuz, A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80243-8 · Cited by 305
Gary-Bobo, M., Elachouri, G., Gallas, J. F., Janiak, P., Marini, P., Ravinet-Trillou, C., Chabbert, M., Cruccioli, N., Pfersdorff, C., Roque, C., et al. (2007) · Hepatology · doi:10.1002/hep.21641 · Cited by 304
The Role of Ultrasound in the Diagnosis of Hepatic Steatosis in Morbidly Obese Patients
Mottin, C. C., Moretto, M., Padoin, A. V., Swarowsky, A. M., Toneto, M. G., Glock, L., & Repetto, G. (2004) · Obesity Surgery · doi:10.1381/096089204323093408 · Cited by 301
Safety of oral intake of vitamin E
Bendich, A., & Bendich, L. (1988) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/48.3.612 · Cited by 293
Piekarski, J., Goldberg, H. I., Royal, S. A., Axel, L., & Moss, A. A. (1980) · Radiology · doi:10.1148/radiology.137.3.6934563 · Cited by 291
Klein, S., Mittendorfer, B., Eagon, J. C., Patterson, B., Grant, L., Feirt, N., Seki, E., Brenner, D., Korenblat, K., & McCrea, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.042 · Cited by 289
Ikejima, K., Honda, H., Yoshikawa, M., Hirose, M., Kitamura, T., Takei, Y., & Sato, N. (2001) · Hepatology · doi:10.1053/jhep.2001.26518 · Cited by 288
Uncertain Effects of Rosiglitazone on the Risk for Myocardial Infarction and Cardiovascular Death
Diamond, G. A., Bax, L., & Kaul, S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00182 · Cited by 288
Hepatic MRI for Fat Quantitation: Its Relationship to Fat Morphology, Diagnosis, and Ultrasound
Fishbein, M., Castro, F., Cheruku, S., Jain, S., Webb, B., Gleason, T., & Stevens, W. R. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200508000-00012 · Cited by 277
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.013 · Cited by 272 · cited 1×
“[177] recently published a retrospective histologic review comparing 51 patients who did not receive statins with 17 patients who received a statin for an average of 6.”
BackgroundLee, J. Y., Kim, K. M., Lee, S. G., Yu, E., Lim, Y.-S., Lee, H. C., Chung, Y.-H., Lee, Y. S., & Suh, D.-J. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.007 · Cited by 272
What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific?
Fan, J., Saibara, T., Chitturi, S., Kim, B. I., Sung, J. J. Y., Chutaputti, A., & NAFLD, T. A. W. P. F. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04952.x · Cited by 267
Bordet, T., Buisson, B., Michaud, M., Drouot, C., Galéa, P., Delaage, P., Akentieva, N. P., Evers, A. S., Covey, D. F., Ostuni, M. A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123000 · Cited by 266
Serum leptin levels in patients with nonalcoholic steatohepatitis
Uygun, A. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02090-6 · Cited by 256
Body fat distribution, relative weight, and liver enzyme levels: A population-based study
Stranges, S., Dorn, J. M., Muti, P., Freudenheim, J. L., Farinaro, E., Russell, M., Nochajski, T. H., & Trevisan, M. (2004) · Hepatology · doi:10.1002/hep.20149 · Cited by 233
Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver
Honda, H., Ikejima, K., Hirose, M., Yoshikawa, M., Lang, T., Enomoto, N., Kitamura, T., Takei, Y., & Sato, N. (2002) · Hepatology · doi:10.1053/jhep.2002.33684 · Cited by 222
Palekar, N. A., Naus, R., Larson, S. P., Ward, J., & Harrison, S. A. (2006) · Liver International · doi:10.1111/j.1478-3231.2005.01209.x · Cited by 216
Suzuki, A., Angulo, P., Lymp, J., Li, D., Satomura, S., & Lindor, K. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01064.x · Cited by 214
Serum cytokine and soluble cytokine receptor levels in patients with non‐alcoholic steatohepatitis
Abiru, S., Migita, K., Maeda, Y., Daikoku, M., Ito, M., Ohata, K., Nagaoka, S., Matsumoto, T., Takii, Y., Kusumoto, K., et al. (2006) · Liver International · doi:10.1111/j.1478-3231.2005.01191.x · Cited by 209
Ursodeoxycholic Acid and Atorvastatin in the Treatment of Nonalcoholic Steatohepatitis
Kiyici, M., Gulten, M., Gurel, S., Nak, S. G., Dolar, E., Savci, G., Adim, S. B., Yerci, O., & Memik, F. (2003) · Canadian Journal of Gastroenterology · doi:10.1155/2003/857869 · Cited by 199
Troglitazone-Induced Hepatic Failure Leading to Liver Transplantation: A Case Report
Neuschwander-Tetri, B. A., Isley, W. L., Oki, J. C., Ramrakhiani, S., Quiason, S. G., Phillips, N. J., & Brunt, E. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-1-199807010-00009 · Cited by 195
Pathogenesis of Non-alcoholic Steatohepatitis: Human Data
Edmison, J., & McCullough, A. J. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.011 · Cited by 193
A pilot study of atorvastatin treatment in dyslipemid, non‐alcoholic fatty liver patients
GÓMEZ‐DOMÍNGUEZ, E., GISBERT, J. P., MORENO‐MONTEAGUDO, J. A., GARCÍA‐BUEY, L., & MORENO‐OTERO, R. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02926.x · Cited by 189
Pediatric nonalcoholic fatty liver disease (NAFLD): A “growing” problem?
Roberts, E. A. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.003 · Cited by 181
Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT.
Jacobs, J. E., Birnbaum, B. A., Shapiro, M. A., Langlotz, C. P., Slosman, F., Rubesin, S. E., & Horii, S. C. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.171.3.9725292 · Cited by 181
Lee, S. W., Park, S. H., Kim, K. W., Choi, E. K., Shin, Y. M., Kim, P. N., Lee, K. H., Yu, E. S., Hwang, S., & Lee, S.-G. (2007) · Radiology · doi:10.1148/radiol.2442061177 · Cited by 181
Osawa, H., & Mori, Y. (1996) · Journal of Clinical Ultrasound · doi:10.1002/(sici)1097-0096(199601)24:1<25::aid-jcu4>3.0.co;2-n · Cited by 178
Natural History of NAFLD: Remarkably Benign in the Absence of Cirrhosis
Day, C. P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.041 · Cited by 176
Targher, G., Bertolini, L., Rodella, S., Zoppini, G., Scala, L., Zenari, L., & Falezza, G. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02527.x · Cited by 172
Chalasani, N. P., Sanyal, A. J., Kowdley, K. V., Robuck, P. R., Hoofnagle, J., Kleiner, D. E., Ünalp, A., & Tonascia, J. (2009) · Contemporary Clinical Trials · doi:10.1016/j.cct.2008.09.003 · Cited by 168
Yilmaz, Y. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i6.837 · Cited by 168
Parés, A. R., Deulofeu, R., Giménez, A., Caballería, L., Bruguera, M., Caballería, J., Ballesta, A. M., & Rodés, J. (1996) · Hepatology · doi:10.1002/hep.510240615 · Cited by 163
Is NASH underdiagnosed among African Americans?
Caldwell, S. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04151-5 · Cited by 161
Mitochondrial injury in steatohepatitis
Pessayre, D., Fromenty, B., & Mansouri, A. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200411000-00003 · Cited by 161
Vendemiale, G., Grattagliano, I., Caraceni, P., Caraccio, G., Domenicali, M., Dall'Agata, M., Trevisani, F., Guerrieri, F., Bernardi, M., & Altomare, E. (2001) · Hepatology · doi:10.1053/jhep.2001.23060 · Cited by 160
Does Leptin Play A Role in The Pathogenesis of Human Nonalcoholic Steatohepatitis?
Chalasani, N., Crabb, D. W., Cummings, O. W., Kwo, P. Y., Asghar, A., Pandya, P., & Considine, R. V. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.08767.x · Cited by 158
The Evolution of Severe Steatosis After Bariatric Surgery Is Related to Insulin Resistance
Mathurin, P., Gonzalez, F., Kerdraon, O., Leteurtre, E., Arnalsteen, L., Hollebecque, A., Louvet, A., Dharancy, S., Cocq, P., Jany, T., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.024 · Cited by 158
Hatzitolios, A. I., Savopoulos, C., Lazaraki, G., Sidiropoulos, I., Haritanti, P., Lefkopoulos, A., Karagiannopoulou, G., Tzioufa, & Dimitrios, K. (2004) · PubMed · Cited by 154
Song, Z., Deaciuc, I. V., Zhou, Z., Song, M., Chen, T., Hill, D. B., & McClain, C. J. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00133.2007 · Cited by 141
Sato, F., Tamura, Y., Watada, H., Kumashiro, N., Igarashi, Y., Uchino, H., Maehara, T., Kyogoku, S., Sunayama, S., Sato, H., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2384 · Cited by 140
Nonalcoholic fatty liver disease in the pediatric population: a review
Wieckowska, A., & Feldstein, A. E. (2005) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000172816.79637.c5 · Cited by 132
Incretin mimetics as a novel therapeutic option for hepatic steatosis
Tushuizen, M. E., Bunck, M. C. M., Pouwels, P. J. W., van Waesberghe, J. H. T., Diamant, M., & Heine, R. J. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01315.x · Cited by 127
Sabuncu, T., Nazlıgül, Y., Karaoğlanoğlu, M., Uçar, E., & Kilic, F. B. (2003) · PubMed · Cited by 126
Nobili, V., Manco, M., Ciampalini, P., Alisi, A., Vito, R. D., Bugianesi, E., MARCELLINI, M., & Marchesini, G. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.06.012 · Cited by 125
NAFLD, Obesity, and Bariatric Surgery
Angulo, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.041 · Cited by 124
The evolving role of liver biopsy
Campbell, M. S., & Reddy, K. R. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02071.x · Cited by 118
Health risks among Japanese men with moderate body mass index
Hsieh, S. D., Yoshinaga, H., Muto, T., Sakurai, Y., & Kosáka, K. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801157 · Cited by 112
Efficacy and Safety of Oral Betaine Glucuronate in Non-alcoholic Steatohepatitis
Miglio, F., Rovati, L. C., Santoro, A., & Setnikar, I. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300279 · Cited by 106
Ryan, M. C., Abbasi, F., Lamendola, C. A., Carter, S., & McLaughlin, T. (2007) · Diabetes Care · doi:10.2337/dc06-2169 · Cited by 106
Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation
Molloy, R. M., KOMOROWSKI, R. A., & Varma, R. R. (1997) · Liver Transplantation and Surgery · doi:10.1002/lt.500030212 · Cited by 99
Decrease in accumulation of ultrasound contrast microbubbles in non‐alcoholic steatohepatitis
Iijima, H., Moriyasu, F., Tsuchiya, K., Suzuki, S., Yoshida, M., Shimizu, M., Sasaki, S., Nishiguchi, S., & Maeyama, S. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00130.x · Cited by 99
Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients
Antonopoulos, S., Mikros, S., Mylonopoulou, M., Kokkoris, S., & Giannoulis, G. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.08.021 · Cited by 96
Weight reduction and long-term maintenance after 18 months treatment with orlistat for obesity
Krempf, M., Jp, L., Allanic, H., Miloradovich, T., Joubert, J., & Attali, J. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802281 · Cited by 95
Orlistat in the treatment of NASH: a case series
Harrison, S. A., Ramrakhiani, S., Brunt, E. M., Anbari, M. A., Cortese, C. M., & Bacon, B. R. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07375.x · Cited by 94
Non-Alcoholic Fatty Liver Disease in Young Adult Severely Obese Non-Diabetic Patients in South Italy
Colicchio, P., Tarantino, G., del Genio, F., Sorrentino, P., Saldalamacchia, G., Finelli, C., Conca, P., Contaldo, F., & Pasanisi, F. (2005) · Annals of Nutrition and Metabolism · doi:10.1159/000087295 · Cited by 93
Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis
Ramalho, R. M., Cortez‐Pinto, H., Castro, R. E., Sol, S., Costa, A. L., de Moura, M. C., Camilo, M., & Rodrigues, C. L. M. P. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200601000-00005 · Cited by 93
Tarantino, G., Conca, P., Riccio, A., Tarantino, M., Minno, M. N. D. D., Chianese, D., Pasanisi, F., Contaldo, F., Scopacasa, F., & Capone, D. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-72 · Cited by 89
Balas, B., Belfort, R., Harrison, S. A., Darland, C., Finch, J., Schenker, S., Gastaldelli, A., & Cusi, K. J. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.013 · Cited by 88
The Prevalence of Nonalcoholic Steatohepatitis is Greater in Morbidly Obese Men Compared to Women
Arun, J. S., Clements, R. H., Lazenby, A. J., Leeth, R. R., & Abrams, G. A. (2006) · Obesity Surgery · doi:10.1381/096089206778663715 · Cited by 77
Effect of weight control on hepatic abnormalities in obese patients with fatty liver
Park, H. S., Kim, M. W., & Shin, E. S. (1995) · Journal of Korean Medical Science · doi:10.3346/jkms.1995.10.6.414 · Cited by 76
Wu, H., Jia, W., Bao, Y., Lu, J., Zhu, J., Wang, R., Chen, Y., & Xiang, K. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.08.016 · Cited by 76
Leen, E. L. S., Goldberg, J. A., Angerson, W. J., & McArdle, C. S. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06322-9 · Cited by 74
Blood oxidative stress markers are unreliable markers of hepatic steatosis
Bonnefont‐Rousselot, D., Ratziu, V., Giral, P., Charlotte, F., Beucler, I., Poynard, T., & FOR THE LIDO STUDY GROUP (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02719.x · Cited by 70
Horoz, M., Bölükbaş, C., Bolukbas, F. F., Sabuncu, T., Aslan, M., Sarifakiogullari, S., Gunaydin, N., & Erel, Ö. (2005) · BMC Gastroenterology · doi:10.1186/1471-230x-5-35 · Cited by 62
Petta, S., Cammà, C., Marco, V. D., Alessi, N., Barbaria, F., Cabibi, D., Caldarella, R., Ciminnisi, S., Licata, A., Massenti, M. F., et al. (2008) · Hepatology · doi:10.1002/hep.22316 · Cited by 61
Poylin, V., Serrot, F. J., Madoff, R. D., Ikrumuddin, S., Mellgren, A., Lowry, A. C., & Melton, G. B. (2011) · Colorectal Disease · doi:10.1111/j.1463-1318.2011.02584.x · Cited by 58
Lincoff, A. M., Wolski, K., Nicholls, S. J., & Nissen, S. E. (2007) · JAMA · doi:10.1001/jama.298.10.1180 · Cited by 52
Tarantino, G., Conca, P., Coppola, A., Vecchione, R., & Minno, G. D. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01745.x · Cited by 48
dos Santos, V. N., Lanzoni, V. P., Szejnfeld, J., Shigueoka, D. C., & Parise, E. R. (2003) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2003000600007 · Cited by 44
Madan, K., Batra, Y., Gupta, D., Chander, B., Rajan, A., Singh, R., Panda, S. K., & Acharya, S. K. (2005) · PubMed · Cited by 31
Wang, Z., Xia, B., Ma, C., Hu, Z., Chen, X., & Cao, P. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.052258 · Cited by 29
Fatty Liver in Obesity: Relation to Doppler Perfusion Index Measurement of the Liver
Kakkos, S. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200750023066 · Cited by 27
The rise and fall of troglitazone
Bailey, C. J. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00315.x · Cited by 27
Noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis C.
Castéra, L., & Pawlotsky, J. (2005) · PubMed · Cited by 26
Prevention and Reversal of Liver Damage following Biliopancreatic Diversion for Obesity
Antal, S. C. (1994) · Obesity Surgery · doi:10.1381/096089294765558520 · Cited by 25
Metformin: a useful adjunct to insulin therapy?
Bailey, C. J. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00216-7.x · Cited by 16
Review: Current status of therapy in nonalcoholic fatty liver disease
McNear, S., & Harrison, S. A. (2009) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x08100327 · Cited by 15
Does retinol‐binding protein 4 cause or reflect fatty liver disease?†‡
Blüher, M., Tönjes, A., & Stümvoll, M. (2008) · Hepatology · doi:10.1002/hep.22426 · Cited by 14
Mitochondrial dysfunction and insulin resistance: a matter of lifestyle?
L??, K.-A., Tappy, L., & Alessio, D. D. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3281e72abf · Cited by 9
Daugherty, K. K., & Subramanian, J. (2007) · Journal of Pharmacy Practice · doi:10.1177/0897190007303052 · Cited by 2
Cited by
Energy Metabolism in the Liver
Rui, L. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130024 · Cited by 1,953
Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP‐1c
Ferré, P., & Foufelle, F. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01275.x · Cited by 704
Hepatic Steatosis: Quantification by Proton Density Fat Fraction with MR Imaging versus Liver Biopsy
Idilman, I. S., Aniktar, H., Idilman, R., Kabacam, G., Savas, B., Elhan, A., Celik, A., Bahar, K., & Karcaaltincaba, M. (2013) · Radiology · doi:10.1148/radiol.13121360 · Cited by 389
Molecular pathways in non-alcoholic fatty liver disease
Auguet, T., Berlanga, A., Guiu-Jurado, E., & Porras, J. A. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s62831 · Cited by 379
Role of Mitochondria in Nonalcoholic Fatty Liver Disease
Nassir, F., & Ibdah, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058713 · Cited by 364
Metadata
- Authors
- Lewis, J. R., & Mohanty, S. R.
- Venue
- Digestive Diseases and Sciences
- Published
- 2010-01-26
- Volume
- 55
- Issue
- 3
- Pages
- 560-578
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2090802204
- Cited by
- 345
- References
- 174
- FWCI
- 29.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.